Moreover, HKII expression is also regulated by p53, a key tumor suppressor protein frequently mutated in various subtypes of epithelial ovarian cancer and associated with chemoresistance development, tumor progression, metastasis, and adverse clinical outcomes [2,83]. Here, TP53 is linked to ovarian carcinoma.